Anxiety / mood 2026

Lion's mane and a Lion's mane+Reishi blend for anxiety in young women: a 4-week RCT (n=84)

A Northumbria University RCT: 84 women aged 18–26 with subjective stress/anxiety received 1.8 g/day of powdered Lion's mane, a Lion's mane+Reishi blend, or placebo for 28 days. On the primary GAD-7 outcome the blend outperformed Lion's mane overall (p=0.018) and at day 28 (p=0.003); secondary anxiety and stress scales fell to trend level after FDR correction. All groups improved — in part a 'participatory' effect.

Smith E.F., Docherty S. The effects of four-week supplementation of Lion's mane and a Lion's mane and Reishi blend on prioritised mood and wellbeing measures in young women. Front Nutr. 2026;13:1887408.

Rationale

Functional mushrooms are sold "for mood", yet proper RCTs are rare. This work is a welcome example of sound design: double-blind, placebo, registered protocol (NCT06406946) and honest caveats about the strength of its conclusions.

Methods

84 women aged 18–26 with subjective stress/anxiety (Gen Z — a deliberately chosen population); 3 arms: 1.8 g Lion's mane, 1.8 g LM+Reishi blend, placebo — 28 days, weekly measures plus day-42 follow-up. A preliminary sort-and-rank exercise set the priority outcomes (GAD-7 primary).

Results

  • Primary GAD-7: the LM+Reishi blend beat Lion's mane alone overall (p=0.018) and at day 28 (p=0.003).
  • Secondary HADS and PSS attenuated to trend-level after multiple-comparison correction.
  • All three arms, including placebo, improved significantly on every scale — a "participatory" effect of care and routine.

Authors' conclusions

The LM+Reishi blend improved the primary anxiety outcome versus Lion's mane alone; secondary findings need confirmation in adequately powered trials. Key methodological questions — dose, duration, blend composition — remain open.

Worth noting

An honest card: the only statistically robust result is blend > single LM, not "mushrooms > placebo". The difference from placebo on the primary outcome was not shown convincingly, and the participatory effect (improvement in all arms) is the classic trap of soft endpoints. This is not "LM treats anxiety" — it is "a signal that the combination may work better than single LM; more data needed".